Valora Therapeutics
Pre-clinicalAt Valora Therapeutics, we are not just developing therapies; we aim to restore the defective language of immune communication in disease. Our proprietary AbLec™ platform decodes the complex sugar code of cellular to immune interactions, unlocking new possibilities in immunotherapy.
Founded
2020
Focus
AntibodiesBiologics
About
At Valora Therapeutics, we are not just developing therapies; we aim to restore the defective language of immune communication in disease. Our proprietary AbLec™ platform decodes the complex sugar code of cellular to immune interactions, unlocking new possibilities in immunotherapy.
Funding History
2Total raised: $60M
Series A$45MMorningside VenturesSep 15, 2023
Seed$15MMorningside VenturesApr 15, 2022
Company Info
TypePrivate
Founded2020
LocationSan Francisco, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile